Could vitamin c ease anemia in rare blood disorders? new study begins

NCT ID NCT07612345

First seen May 31, 2026 · Last updated Jun 08, 2026 · Updated 2 times

Summary

This early-stage study tests whether high doses of Vitamin C are safe for adults with two rare inherited blood disorders—Pyruvate Kinase Deficiency (PKD) and a type of G6PD deficiency. These conditions cause red blood cells to break down too quickly, leading to anemia. Participants will take Vitamin C up to three times daily for three weeks while researchers monitor blood counts and side effects. The goal is to find a safe dose that might reduce anemia and improve quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PYRUVATE KINASE DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Utah

    Salt Lake City, Utah, 84112, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.